Docket Nexus — Federal court records.
Patent - ANDA Lawsuit

Bausch & Lomb, Inc v. Slayback Pharma LLC

Patent - ANDA Terminated 11/27/2024 District Court, D. New Jersey

Bausch & Lomb, Inc v. Slayback Pharma LLC is a federal patent - anda lawsuit filed on 09/10/2021 in the District Court, D. New Jersey. The case was terminated on 11/27/2024.

Court
District Court, D. New Jersey (D.N.J.)
Official Court Website →
Assigned judge
Robert Kirsch · 259 cases in index
Docket number
3:21-cv-16766
Cause
35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement
Nature of suit
835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.
Jurisdiction
Federal Question
Jury demand
None
Date filed
09/10/2021
Date terminated
11/27/2024

623 Patent - ANDA cases in this court are indexed here.

Parties

Part of a Larger Litigation Pattern

This is one of 16 Patent - ANDA cases in our index naming Slayback Pharma LLC — a possible mass-tort or coordinated-litigation cluster.

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Bausch & Lomb, Inc v. Slayback Pharma LLC?

Bausch & Lomb, Inc v. Slayback Pharma LLC is a federal patent - anda lawsuit filed on 09/10/2021 in the District Court, D. New Jersey. The case was terminated on 11/27/2024. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, D. New Jersey, docket number 3:21-cv-16766.

When was the case filed?

Bausch & Lomb, Inc v. Slayback Pharma LLC was filed on 09/10/2021. It was terminated on 11/27/2024.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.

Other Cases Involving These Parties

Related Patent - ANDA Cases

Source: public U.S. federal court record (docket 60377524).